GSI 7985 (Harvoni ledipasvir 90 mg / sofosbuvir 400 mg)

Generic Name: ledipasvir/sofosbuvir

Pill imprint GSI 7985 has been identified as Harvoni ledipasvir 90 mg / sofosbuvir 400 mg.

Harvoni is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Harvoni ledipasvir 90 mg / sofosbuvir 400 mg is not a controlled substance under the Controlled Substance Act (CSA).

Harvoni

Generic Name:

ledipasvir/sofosbuvir

Imprint:

GSI 7985

Strength:

ledipasvir 90 mg / sofosbuvir 400 mg

Color:

Orange

Shape:

Four-sided

Availability:

Prescription only

Drug Class:

Antiviral combinations

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Gilead Sciences, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.